Ravulizumab IV Infusion (Великобритания (Англия, Шотландия, Уэльс) - Тендер #45803178)

Print or Save this Notice Download PDF Download HTML Download XML

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

BELFAST HEALTH AND SOCIAL CARE TRUST

LISBURN ROAD

BELFAST

BT97AB

UK

Contact person: Norma Moore

E-mail: norma.moore@belfasttrust.hscni.net

NUTS: UKN06

Internet address(es)

Main address: https://belfasttrust.hscni.net/

I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Ravulizumab IV Infusion

Reference number: DACPM2023-67

II.1.2) Main CPV code

33000000

II.1.3) Type of contract

Supplies

II.1.4) Short description

Procurement of Ravulizumab IV Infusion

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 320 000.00 GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UKN

Main site or place of performance:

Belfast Health & Social Care Trust

II.2.4) Description of the procurement

Procurement of Ravulizumab IV Infusion

II.2.5) Award criteria

Price

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The works, supplies or services can be provided only by a particular economic operator for the following reason: protection of exclusive rights, including intellectual property rights

Explanation

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section V: Award of contract

Contract No: DACPM2023-67

Title: Ravulizumab IV Infusion

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

01/09/2023

V.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Alexion Pharma UK Ltd

05970106

3 Furzeground Way Stockley Park

Uxbridge

UB11 1EZ

UK

NUTS: UKJ

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 320 000.00 GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

Belfast Health and Social Care Trust

Belfast

BT8 8BH

UK

E-mail: norma.moore@belfasttrust.hscni.net

Internet address(es)

URL: https://belfasttrust.hscni.net/

VI.5) Date of dispatch of this notice

04/09/2023

Information added to the notice since publication.

Additional information added to the notice since it"s publication.

Commodity Categories

Commodity Categories

Delivery Locations

Delivery Locations

Alert Region Restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

Alert Region Restrictions

Источник закупки

Перейти

Импорт - Экспорт по стране Великобритания (Англия, Шотландия, Уэльс)